PIRS
Price
$13.60
Change
-$2.53 (-15.69%)
Updated
Dec 13 closing price
RNAC
Price
$19.04
Change
-$0.23 (-1.19%)
Updated
Dec 20, 04:59 PM (EDT)
Ad is loading...

PIRS vs RNAC

Header iconPIRS vs RNAC Comparison
Open Charts PIRS vs RNACBanner chart's image
Pieris Pharmaceuticals
Price$13.60
Change-$2.53 (-15.69%)
Volume$51.73K
CapitalizationN/A
Cartesian Therapeutics
Price$19.04
Change-$0.23 (-1.19%)
Volume$5.06K
CapitalizationN/A
PIRS vs RNAC Comparison Chart
Loading...
PIRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PIRS vs. RNAC commentary
Dec 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PIRS is a Hold and RNAC is a Hold.

COMPARISON
Comparison
Dec 22, 2024
Stock price -- (PIRS: $13.60 vs. RNAC: $19.02)
Brand notoriety: PIRS and RNAC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PIRS: 175% vs. RNAC: 598%
Market capitalization -- PIRS: $17.96M vs. RNAC: $483.14M
PIRS [@Biotechnology] is valued at $17.96M. RNAC’s [@Biotechnology] market capitalization is $483.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PIRS’s FA Score shows that 1 FA rating(s) are green whileRNAC’s FA Score has 0 green FA rating(s).

  • PIRS’s FA Score: 1 green, 4 red.
  • RNAC’s FA Score: 0 green, 5 red.
According to our system of comparison, RNAC is a better buy in the long-term than PIRS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PIRS’s TA Score shows that 4 TA indicator(s) are bullish while RNAC’s TA Score has 5 bullish TA indicator(s).

  • PIRS’s TA Score: 4 bullish, 5 bearish.
  • RNAC’s TA Score: 5 bullish, 6 bearish.
According to our system of comparison, both PIRS and RNAC are a bad buy in the short-term.

Price Growth

PIRS (@Biotechnology) experienced а 0.00% price change this week, while RNAC (@Biotechnology) price change was +1.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.22%. For the same industry, the average monthly price growth was -1.31%, and the average quarterly price growth was +0.77%.

Reported Earning Dates

PIRS is expected to report earnings on Aug 01, 2024.

RNAC is expected to report earnings on Aug 08, 2024.

Industries' Descriptions

@Biotechnology (-2.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RNAC($483M) has a higher market cap than PIRS($18M). PIRS YTD gains are higher at: -6.593 vs. RNAC (-8.036). PIRS has less debt than RNAC: PIRS (0) vs RNAC (10.5M).
PIRSRNACPIRS / RNAC
Capitalization18M483M4%
EBITDAN/AN/A-
Gain YTD-6.593-8.03682%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total Cash89.9MN/A-
Total Debt010.5M-
FUNDAMENTALS RATINGS
PIRS vs RNAC: Fundamental Ratings
PIRS
RNAC
OUTLOOK RATING
1..100
5060
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
99
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9897
PRICE GROWTH RATING
1..100
5648
P/E GROWTH RATING
1..100
10042
SEASONALITY SCORE
1..100
n/a95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PIRS's Valuation (25) in the Biotechnology industry is significantly better than the same rating for RNAC (99). This means that PIRS’s stock grew significantly faster than RNAC’s over the last 12 months.

PIRS's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as RNAC (100). This means that PIRS’s stock grew similarly to RNAC’s over the last 12 months.

RNAC's SMR Rating (97) in the Biotechnology industry is in the same range as PIRS (98). This means that RNAC’s stock grew similarly to PIRS’s over the last 12 months.

RNAC's Price Growth Rating (48) in the Biotechnology industry is in the same range as PIRS (56). This means that RNAC’s stock grew similarly to PIRS’s over the last 12 months.

RNAC's P/E Growth Rating (42) in the Biotechnology industry is somewhat better than the same rating for PIRS (100). This means that RNAC’s stock grew somewhat faster than PIRS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PIRSRNAC
RSI
ODDS (%)
Bullish Trend 10 days ago
73%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 10 days ago
77%
Bullish Trend 3 days ago
81%
Momentum
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 3 days ago
86%
MACD
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 10 days ago
87%
Bullish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 10 days ago
87%
Bullish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 13 days ago
83%
Bullish Trend 17 days ago
84%
Declines
ODDS (%)
Bearish Trend 10 days ago
84%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 10 days ago
79%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
81%
View a ticker or compare two or three
Ad is loading...
PIRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME29.820.82
+2.83%
GameStop Corp
AAPL254.494.70
+1.88%
Apple
SPY591.157.02
+1.20%
SPDR® S&P 500® ETF Trust
BTC.X97224.730000-531.203100
-0.54%
Bitcoin cryptocurrency
TSLA421.06-15.11
-3.46%
Tesla

PIRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, PIRS has been closely correlated with CDTX. These tickers have moved in lockstep 96% of the time. This A.I.-generated data suggests there is a high statistical probability that if PIRS jumps, then CDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PIRS
1D Price
Change %
PIRS100%
N/A
CDTX - PIRS
96%
Closely correlated
+3.15%
NCNA - PIRS
95%
Closely correlated
N/A
NBY - PIRS
95%
Closely correlated
+5.12%
SNPX - PIRS
94%
Closely correlated
+19.69%
RNAC - PIRS
94%
Closely correlated
-1.30%
More

RNAC and

Correlation & Price change

A.I.dvisor indicates that over the last year, RNAC has been closely correlated with PIRS. These tickers have moved in lockstep 94% of the time. This A.I.-generated data suggests there is a high statistical probability that if RNAC jumps, then PIRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNAC
1D Price
Change %
RNAC100%
-1.30%
PIRS - RNAC
94%
Closely correlated
N/A
WINT - RNAC
94%
Closely correlated
-1.48%
NCNA - RNAC
92%
Closely correlated
N/A
CDTX - RNAC
92%
Closely correlated
+3.15%
NBY - RNAC
91%
Closely correlated
+5.12%
More